Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Obstructive Lung Diseases

Free Subscription 30.05.2022 3 Allergy 2 Am J Respir Crit Care Med 2 Ann Allergy Asthma Immunol 7 Eur Respir J 1 J Allergy Clin Immunol 2 J Asthma 2 Pediatr Allergy Immunol 1 Pediatr Pulmonol 1 PLoS One 2 Respir Med 1 Respir Res 2 Rev Mal Respir

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Allergy

1. ANDIAPPAN AK, Puan KJ, Sio YY, Ally F, et al
   Functional CTLA-4 variants associate to both allergic asthma and rhinitis potentially by modulating naive regulatory T cells.
   Allergy. 2022 May 24. doi: 10.1111/all.15386.
   PubMed        
   
   
2. CARRARO S, di Palmo E, Licari A, Barni S, et al
   Metabolomics to identify omalizumab responders among children with severe asthma: a prospective study.
   Allergy. 2022 May 23. doi: 10.1111/all.15385.
   PubMed        
   
   
3. KALLIERI M, Zervas E, Fouka E, Porpodis K, et al
   RELIght: A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: evaluating the multiple components of response.
   Allergy. 2022 May 20. doi: 10.1111/all.15382.
   PubMed        
   
   

   
   Am J Respir Crit Care Med

4. RUNNSTROM MC, Lee FE
   Reply to: SARS-CoV-2 mRNA Vaccine Antibody Response in Asthma Patients with Biologic Therapy after Second and Booster Dose: A Real-world Analysis.
   Am J Respir Crit Care Med. 2022 May 25. doi: 10.1164/rccm.202205-0979.
   PubMed        
   
   
5. SCHUYLER AJ, Wenzel SE
   Historical Redlining Impacts Contemporary Environmental and Asthma-Related Outcomes in Black Adults.
   Am J Respir Crit Care Med. 2022 May 25. doi: 10.1164/rccm.202112-2707.
   PubMed         Abstract available
   
   

   
   Ann Allergy Asthma Immunol

6. LIPWORTH DB, Stewart MK, Chan DR
   Pragmatic reappraisal of long acting muscarinic antagonists at steps 4/5 for persistent adult asthma: Invited Perspective article for Annals of Allergy, Asthma and Immunology.
   Ann Allergy Asthma Immunol. 2022 May 22. pii: S1081-1206(22)00449.
   PubMed        
   
   
7. HUDDLESTON CM, Slaven JE, Weist AD, Krupp NL, et al
   Increased Healthcare Utilization in Moderate to Severe Asthma Patients Due to Frequent Preferred Medication Changes.
   Ann Allergy Asthma Immunol. 2022 May 21. pii: S1081-1206(22)00448.
   PubMed        
   
   

   
   Eur Respir J

8. KAASGAARD M, Rasmussen DB, Andreasson KH, Hilberg O, et al
   Use of Singing for Lung Health as an alternative training modality within pulmonary rehabilitation for COPD: a randomised controlled trial.
   Eur Respir J. 2022;59.
   PubMed         Abstract available
   
   
9. YUN JH, Lee S, Srinivasa P, Morrow J, et al
   An interferon-inducible signature of airway disease from blood gene expression profiling.
   Eur Respir J. 2022;59.
   PubMed         Abstract available
   
   
10. VESTBO J, Waterer G, Leather D, Crim C, et al
    Mortality after admission with pneumonia is higher than after admission with an exacerbation of COPD.
    Eur Respir J. 2022;59.
    PubMed        
    
    
11. SORIANO JB, Hopkinson NS
    Sing out for COPD!
    Eur Respir J. 2022;59.
    PubMed        
    
    
12. HUMBERT M, Bourdin A, Taille C, Kamar D, et al
    Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of pediatric and adult asthmatics.
    Eur Respir J. 2022 May 26. pii: 13993003.03130-2021.
    PubMed         Abstract available
    
    
13. SUN Y, Zhang M, Ou Z, Meng Y, et al
    Indoor microbiome, microbial and plant metabolites, chemical compounds and asthma symptoms in junior high school students: a multicentre association study in Malaysia.
    Eur Respir J. 2022 May 26. pii: 13993003.00260-2022.
    PubMed         Abstract available
    
    
14. WOEHLK C, Von Bulow A, Ghanizada M, Baastrup Sondergaard M, et al
    Allergen immunotherapy effectively reduces the risk of exacerbations and lower respiratory tract infections in both seasonal and perennial allergic asthma: a nationwide epidemiological study.
    Eur Respir J. 2022 May 26. pii: 13993003.00446-2022.
    PubMed         Abstract available
    
    

    
    J Allergy Clin Immunol

15. CARDET JC, Chang KL, Rooks BJ, Carroll JK, et al
    Socioeconomic status associates with worse asthma morbidity among Black and Latinx adults.
    J Allergy Clin Immunol. 2022 May 18. pii: S0091-6749(22)00661.
    PubMed         Abstract available
    
    

    
    J Asthma

16. OMARA H, Gamal M, Mohamed R
    Asthma Education and its Impact on Pediatric Asthma Severity: A Prospective Cohort Study.
    J Asthma. 2022 May 26:1-16. doi: 10.1080/02770903.2022.2082306.
    PubMed         Abstract available
    
    
17. ALSUWAIGH R, Cao Y, Puan Y, Yii A, et al
    Nebulizer versus metered dose inhaler with space chamber (MDI spacer) for acute asthma and chronic obstructive pulmonary disease (COPD) exacerbation: attitudes of patients and healthcare providers in the COVID-19 era.
    J Asthma. 2022 May 24:1-12. doi: 10.1080/02770903.2022.2082307.
    PubMed         Abstract available
    
    

    
    Pediatr Allergy Immunol

18. HERNANDEZ-PACHECO N, Kere M, Melen E
    Gene-environment interactions in childhood asthma revisited; expanding the interaction concept.
    Pediatr Allergy Immunol. 2022;33:e13780.
    PubMed         Abstract available
    
    
19. GRANT TL, Wood RA
    The influence of urban exposures and residence on childhood asthma.
    Pediatr Allergy Immunol. 2022;33:e13784.
    PubMed         Abstract available
    
    

    
    Pediatr Pulmonol

20. COGO A, Piazza M, Costella S, Appodia M, et al
    A positive effect of a short period stay in Alpine environment on lung function in asthmatic children.
    Pediatr Pulmonol. 2022 May 23. doi: 10.1002/ppul.25987.
    PubMed         Abstract available
    
    

    
    PLoS One

21. ALQAHTANI JS
    Prevalence, incidence, morbidity and mortality rates of COPD in Saudi Arabia: Trends in burden of COPD from 1990 to 2019.
    PLoS One. 2022;17:e0268772.
    PubMed         Abstract available
    
    

    
    Respir Med

22. SON JH, Park JS, Lee JU, Kim MK, et al
    A genome-wide association study on frequent exacerbation of asthma depending on smoking status.
    Respir Med. 2022 May 17:106877. doi: 10.1016/j.rmed.2022.106877.
    PubMed         Abstract available
    
    
23. IKWU I, Nicolas LG, Mehari A, Gillum RF, et al
    Fractional exhaled nitric oxide and mortality in asthma and chronic obstructive pulmonary disease in a national cohort aged 40 years and older.
    Respir Med. 2022 May 16:106879. doi: 10.1016/j.rmed.2022.106879.
    PubMed         Abstract available
    
    

    
    Respir Res

24. IHRIE MD, McQuade VL, Womble JT, Hegde A, et al
    Exogenous leptin enhances markers of airway fibrosis in a mouse model of chronic allergic airways disease.
    Respir Res. 2022;23:131.
    PubMed         Abstract available
    
    

    
    Rev Mal Respir

25. JEBRAK G, Houdouin V, Terrioux P, Lambert N, et al
    [Therapeutic adherence among asthma patients: Variations according to age groups. How can it be improved? The potential contributions of new technologies].
    Rev Mal Respir. 2022 May 18. pii: S0761-8425(22)00101.
    PubMed         Abstract available
    
    
26. MEDRINAL C, Bonnevie T
    [Physiotherapy during and after acute exacerbation of COPD].
    Rev Mal Respir. 2022;39:386-397.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: